Next Article in Journal
Scaling Approaches for Pediatric Dose Selection: The Fremanezumab (AJOVY®) Journey to Select a Phase 3 Dose Using Pharmacokinetic Data from a Phase 1 Study
Next Article in Special Issue
Liposomal Ellagic Acid Alleviates Cyclophosphamide-Induced Toxicity and Eliminates the Systemic Cryptococcus neoformans Infection in Leukopenic Mice
Previous Article in Journal
RETRACTED: Lipidic Nano-Sized Emulsomes Potentiates the Cytotoxic and Apoptotic Effects of Raloxifene Hydrochloride in MCF-7 Human Breast Cancer Cells: Factorial Analysis and In Vitro Anti-Tumor Activity Assessment
Previous Article in Special Issue
Fluconazole and Lipopeptide Surfactin Interplay During Candida albicans Plasma Membrane and Cell Wall Remodeling Increases Fungal Immune System Exposure
 
 
Article

Article Versions Notes

Pharmaceutics 2021, 13(6), 784; https://doi.org/10.3390/pharmaceutics13060784
Action Date Notes Link
article pdf uploaded. 24 May 2021 16:02 CEST Version of Record https://www.mdpi.com/1999-4923/13/6/784/pdf-vor
article xml file uploaded 25 May 2021 09:37 CEST Original file -
article xml uploaded. 25 May 2021 09:37 CEST Update -
article pdf uploaded. 25 May 2021 09:37 CEST Updated version of record https://www.mdpi.com/1999-4923/13/6/784/pdf-vor
article html file updated 25 May 2021 09:39 CEST Original file -
article xml file uploaded 26 May 2021 05:33 CEST Update -
article xml uploaded. 26 May 2021 05:33 CEST Update https://www.mdpi.com/1999-4923/13/6/784/xml
article pdf uploaded. 26 May 2021 05:33 CEST Updated version of record https://www.mdpi.com/1999-4923/13/6/784/pdf
article html file updated 26 May 2021 05:35 CEST Update -
article html file updated 26 July 2022 21:05 CEST Update https://www.mdpi.com/1999-4923/13/6/784/html
Back to TopTop